These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29095107)

  • 41. Role of SLCO1B1, ABCB1, and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients.
    Mei Y; Wang SY; Li Y; Yi SQ; Wang CY; Yang M; Duan KM
    J Clin Pharmacol; 2015 Mar; 55(3):261-8. PubMed ID: 25279974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.
    Soko ND; Chimusa E; Masimirembwa C; Dandara C
    Pharmacogenomics J; 2019 Jun; 19(3):240-248. PubMed ID: 30100615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.
    Yanagimachi M; Naruto T; Hara T; Kikuchi M; Hara R; Miyamae T; Imagawa T; Mori M; Kaneko T; Morita S; Goto H; Yokota S
    Br J Clin Pharmacol; 2011 Feb; 71(2):237-43. PubMed ID: 21219404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis.
    Kato T; Hamada A; Mori S; Saito H
    Drug Metab Pharmacokinet; 2012; 27(2):192-9. PubMed ID: 22104130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can Pharmacogenetic Variants in
    Jelovac M; Kotur N; Ristivojevic B; Pavlovic D; Spasovski V; Damjanov N; Pavlovic S; Zukic B
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Associations of SLCO1B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients].
    Liu S; Chen RX; Li J; Liu XM; Huang HB; Fu Q; Wang CX; Huang M; Li JL
    Yao Xue Xue Bao; 2016 Aug; 51(8):1240-4. PubMed ID: 29897725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms.
    Linskey DW; English JD; Perry DA; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
    Pharmacogenet Genomics; 2020 Dec; 30(9):208-211. PubMed ID: 32453264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of
    Wang Y; Tian Y; Lv P; Chen L; Luo W; Jing X; Li H; Tan Z; Wang Y; Zhou H; Ouyang DS
    Pharmazie; 2017 Jun; 72(6):365-368. PubMed ID: 29442027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic variation in folylpolyglutamate synthase and gamma-glutamyl hydrolase and plasma homocysteine levels in the Singapore Chinese Health Study.
    Oppeneer SJ; Ross JA; Koh WP; Yuan JM; Robien K
    Mol Genet Metab; 2012 Jan; 105(1):73-8. PubMed ID: 22018726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between rs4149056 variant in
    Al-Salameh A; Danchin N; Verstuyft C; Kotti S; Puymirat E; Ferrières J; Schiele F; Coste P; Lemesle G; Cayla G; Becquemont L; Simon T
    Pharmacogenomics; 2020 Feb; 21(3):163-172. PubMed ID: 31967516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
    Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
    Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
    Sandhu A; Ahmad S; Kaur J; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2018 Dec; 37(12):3221-3228. PubMed ID: 30022368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of protective haplotypes of the
    Favela-Mendoza AF; Rodríguez-Rodríguez BG; Rojas-Prado E; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortés G; Rangel-Villalobos H
    Per Med; 2021 Sep; 18(6):533-540. PubMed ID: 34674552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allelic frequencies of polymorphism c.521T>C (rs4149056) favor preemptive
    Németh S; Kriegshäuser G; Hayrapetyan H; Oberkanins C; Sarkisian T
    Drug Metab Pers Ther; 2024 Sep; 39(3):159-161. PubMed ID: 38997114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia.
    Cheng Y; Chen MH; Zhuang Q; Lin BJ; Chen YY; Yang L; Liu MB; Que WC; Qiu HQ
    Pediatr Blood Cancer; 2021 May; 68(5):e28858. PubMed ID: 33501733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group.
    Santos PC; Soares RA; Nascimento RM; Machado-Coelho GL; Mill JG; Krieger JE; Pereira AC
    BMC Med Genet; 2011 Oct; 12():136. PubMed ID: 21992719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
    Moya P; Salazar J; Arranz MJ; Díaz-Torné C; del Río E; Casademont J; Corominas H; Baiget M
    Pharmacogenomics; 2016; 17(1):25-9. PubMed ID: 26652611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals.
    Fu Q; Li YP; Gao Y; Yang SH; Lu PQ; Jia M; Zhang LR
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1269-74. PubMed ID: 23263738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide study of methotrexate clearance replicates SLCO1B1.
    Ramsey LB; Panetta JC; Smith C; Yang W; Fan Y; Winick NJ; Martin PL; Cheng C; Devidas M; Pui CH; Evans WE; Hunger SP; Loh M; Relling MV
    Blood; 2013 Feb; 121(6):898-904. PubMed ID: 23233662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endogenous Metabolites-Mediated Communication Between OAT1/OAT3 and OATP1B1 May Explain the Association Between SLCO1B1 SNPs and Methotrexate Toxicity.
    Martinez D; Muhrez K; Woillard JB; Berthelot A; Gyan E; Choquet S; Andrès CR; Marquet P; Barin-Le Guellec C
    Clin Pharmacol Ther; 2018 Oct; 104(4):687-698. PubMed ID: 29285751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.